Company attributes
Industry
Location
B2X
0
Pitchbook URL
Number of Employees (Ranges)
1 – 100
Founded Date
2014
0Other attributes
Company Operating Status
Active
Gila Topical Lingual Neural Signaling enables delivery of natural peptide hormones with the goal of activating targeted areas of the brain directly implicated in regulating metabolism.
Gila’s lead program is Topical Lingual PYY. The company is pursuing Phase II proof of concept studies under an active IND in the US and additional mechanistic clinical trials OUS.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
